Literature DB >> 32475402

Dissecting contributions of catalytic and reader domains in regulation of histone demethylation.

Nektaria Petronikolou1, James E Longbotham1, Danica Galonić Fujimori2.   

Abstract

Histone demethylases catalyze the removal of methyl marks from histones, an activity associated with transcriptional regulation and DNA damage repair. As these processes are critical for normal physiology, deregulation of histone demethylases is disease causative, and their function and regulation are targets for therapeutic intervention. The larger of two histone demethylase families are Jumonji C (JmjC) demethylases. The members of the JmjC family share a conserved catalytic domain, and often contain non-catalytic domains that "read" the modification state of chromatin. By binding to specific histone modifications, reader domains assist in recruitment and promote accumulation of demethylases at their targets, as well as regulate their activity and substrate specificity. Here, we present protocols for the investigation of this functional coupling between reader and catalytic domains in human histone demethylase KDM5A. Although we use KDM5A and its PHD1 domain as our model system, the procedures presented herein can be applied for the biochemical characterization of other JmjC demethylases and chromatin readers.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromatin; Fluoresecence polarization; Histone demethylases; PHD; Reader domains

Mesh:

Substances:

Year:  2020        PMID: 32475402      PMCID: PMC7725666          DOI: 10.1016/bs.mie.2020.04.015

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  14 in total

Review 1.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

Authors:  Paul A C Cloos; Jesper Christensen; Karl Agger; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

Review 2.  Epidrugs: targeting epigenetic marks in cancer treatment.

Authors:  Cristiana Libardi Miranda Furtado; Maria Claudia Dos Santos Luciano; Renan Da Silva Santos; Gilvan Pessoa Furtado; Manoel Odorico Moraes; Claudia Pessoa
Journal:  Epigenetics       Date:  2019-07-13       Impact factor: 4.528

3.  From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.

Authors:  Jun Liang; Sharada Labadie; Birong Zhang; Daniel F Ortwine; Snahel Patel; Maia Vinogradova; James R Kiefer; Till Mauer; Victor S Gehling; Jean-Christophe Harmange; Richard Cummings; Tommy Lai; Jiangpeng Liao; Xiaoping Zheng; Yichin Liu; Amy Gustafson; Erica Van der Porten; Weifeng Mao; Bianca M Liederer; Gauri Deshmukh; Le An; Yingqing Ran; Marie Classon; Patrick Trojer; Peter S Dragovich; Lesley Murray
Journal:  Bioorg Med Chem Lett       Date:  2017-05-05       Impact factor: 2.823

4.  Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.

Authors:  Rui Fang; Andrew J Barbera; Yufei Xu; Michael Rutenberg; Thiago Leonor; Qing Bi; Fei Lan; Pinchao Mei; Guo-Cheng Yuan; Christine Lian; Junmin Peng; Dongmei Cheng; Guangchao Sui; Ursula B Kaiser; Yang Shi; Yujiang Geno Shi
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

5.  Purification and assay protocols for obtaining highly active Jumonji C demethylases.

Authors:  Swathi Krishnan; Evys Collazo; Patricia A Ortiz-Tello; Raymond C Trievel
Journal:  Anal Biochem       Date:  2011-08-26       Impact factor: 3.365

6.  Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases.

Authors:  John R Horton; Anup K Upadhyay; Hank H Qi; Xing Zhang; Yang Shi; Xiaodong Cheng
Journal:  Nat Struct Mol Biol       Date:  2009-12-20       Impact factor: 15.369

Review 7.  The Jumonji family: past, present and future of histone demethylases in cancer.

Authors:  Gianluigi Franci; Alfonso Ciotta; Lucia Altucci
Journal:  Biomol Concepts       Date:  2014-06

8.  An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.

Authors:  Maia Vinogradova; Victor S Gehling; Amy Gustafson; Shilpi Arora; Charles A Tindell; Catherine Wilson; Kaylyn E Williamson; Gulfem D Guler; Pranoti Gangurde; Wanda Manieri; Jennifer Busby; E Megan Flynn; Fei Lan; Hyo-Jin Kim; Shobu Odate; Andrea G Cochran; Yichin Liu; Matthew Wongchenko; Yibin Yang; Tommy K Cheung; Tobias M Maile; Ted Lau; Michael Costa; Ganapati V Hegde; Erica Jackson; Robert Pitti; David Arnott; Christopher Bailey; Steve Bellon; Richard T Cummings; Brian K Albrecht; Jean-Christophe Harmange; James R Kiefer; Patrick Trojer; Marie Classon
Journal:  Nat Chem Biol       Date:  2016-05-23       Impact factor: 15.040

Review 9.  Functional coupling between writers, erasers and readers of histone and DNA methylation.

Authors:  Idelisse Ortiz Torres; Danica Galonić Fujimori
Journal:  Curr Opin Struct Biol       Date:  2015-11-09       Impact factor: 6.809

10.  Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.

Authors:  James E Longbotham; Cynthia M Chio; Venkatasubramanian Dharmarajan; Michael J Trnka; Idelisse Ortiz Torres; Devrishi Goswami; Karen Ruiz; Alma L Burlingame; Patrick R Griffin; Danica Galonić Fujimori
Journal:  Nat Commun       Date:  2019-01-09       Impact factor: 14.919

View more
  1 in total

1.  Recognition of Histone H3 Methylation States by the PHD1 Domain of Histone Demethylase KDM5A.

Authors:  James E Longbotham; Mark J S Kelly; Danica Galonić Fujimori
Journal:  ACS Chem Biol       Date:  2021-02-23       Impact factor: 4.634

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.